Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc (ATXI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.4M; returns 1 day -4.8%, 1 week -10.5%, 1 year -45.8%.

Avenue Therapeutics, Inc. is a specialty pharmaceutical company whose business model is almost entirely focused on the development and commercialization of a single late-stage asset: an intravenous (IV) formulation of tramadol for the management of moderate to moderately severe post-operative pain. The company currently generates no recurring revenue from product sales.

Groups ATXI belongs to

• Healthcare
• Pharmaceuticals
• Biotechnology
• Clinical Stage
• Clinical Stage Biopharma
• Pain Management
• Life Sciences
• Biopharmaceutical

ATXI financial model: income statement, cash flow and balance sheet